Abstract

The concentrations of serum osteocalcin (OCN) and calcitonin (CTN) were determined in sixty male workers exposed to fluoride (F) at an aluminum plant in Danjiang city, and in thirty non-F exposed males of the same general age from the local market town Gaolou village of Jun county in Danjiang city (control group). The F-exposed workers were divided into two groups according to the levels of their urine and serum F: a high-F burden group (urine F>4.0 mg/L; serum F>0.20 mg/L) and a low-F burden group (2.0 mg/L<urine F ?4.0 mg/L; 0.10 mg/L<serum F ?0.20 mg/L). Compared with the control group, the concentrations of serum OCN and CTN were significantly higher in both the high-F and low-F burden groups (p<0.05). This study found for the first time that the concentrations of serum OCN and CTN increased concurrently in a F-exposed worker population. On the basis of these findings, we propose that serum OCN and CTN might be sensitive biomarkers for detecting early stages of F bone injuries.

• Related Studies :

  • [Hazards of development of occupational fluorosis in manufacture of phosphorus-containing mineral products].

    Complex studies pertaining to the production of phosphorus-containing mineral products detected no cases of occupational fluorosis among workers. The reasons for fluorosis absence in fluorine-exposed workers were analyzed. The total fluorine load was calculated in workers of the main professions. It was demonstrated that fluorine annual intake of 2-4 g

  • [Spinal cord compression in bone fluorosis. Apropos of 4 cases].

    The authors report four cases of spinal cord compression (three at cervical level and one at dorsal level) due to vertebral osteosclerosis secondary to chronic fluoride intoxication. Roentgenograms showed typical diffuse densification of vertebral bodies, calcifications of bony insertions of many ligaments, discs and interosseous membranes. Urinary fluoride was markedly

  • Fluoridation and bone disease in renal patients

    About the Authors: William J Johnson, director of the Mayo Artificial Kidney Center and professor of medicine with the Division of Nephrology at the Mayo Clinic, has been involved in the study of calcium and phosphorus metabolism and renal osteodystrophy, potassium metabolism, and uremic neuropathy. He is past chairman of the Minnesota

  • Plasma fluoride level as a predictor of voriconazole induced periostitis in patients with skeletal pain

    BACKGROUND: Voriconazole is a triazole antifungal medication used for prophylaxis or to treat invasive fungal infections. Inflammation of the periosteum resulting in skeletal pain, known as periostitis, is a reported side effect of long-term voriconazole therapy. The tri-fluorinated molecular structure of voriconazole suggests a possible link between excess fluoride and

  • Skeletal fluorosis with neurological complications

    A case of skeletal fluorosis with spinal cord compression from Kekirawa following consumption of water with high fluoride content for about 20 years is described. The observations of other workers and the present case report show that more extensive field studies among vulnerable populations is indicated in this region. The need to

• Related FAN Content :

  • "Pre-Skeletal" Fluorosis

    As demonstrated by the studies below, skeletal fluorosis may produce adverse symptoms, including arthritic pains, clinical osteoarthritis, gastrointestinal disturbances, and bone fragility, before the classic bone change of fluorosis (i.e., osteosclerosis in the spine and pelvis) is detectable by x-ray. Relying on x-rays, therefore, to diagnosis skeletal fluorosis will invariably fail to protect those individuals who are suffering from the pre-skeletal phase of the disease. Moreover, some individuals with clinical skeletal fluorosis will not develop an increase in bone density, let alone osteosclerosis, of the spine. Thus, relying on unusual increases in spinal bone density will under-detect the rate of skeletal fluoride poisoning in a population.

  • Skeletal Fluorosis: The Misdiagnosis Problem

    It is a virtual certainty that there are individuals in the general population unknowingly suffering from some form of skeletal fluorosis as a result of a doctor's failure to consider fluoride as a cause of their symptoms. Proof that this is the case can be found in the following case reports of skeletal fluorosis written by doctors in the U.S. and other western countries. As can be seen, a consistent feature of these reports is that fluorosis patients--even those with crippling skeletal fluorosis--are misdiagnosed for years by multiple teams of doctors who routinely fail to consider fluoride as a possible cause of their disease.

  • Fluoride & Osteoarthritis

    While the osteoarthritic effects that occurred from fluoride exposure were once considered to be limited to those with skeletal fluorosis, recent research shows that fluoride can cause osteoarthritis in the absence of traditionally defined fluorosis. Conventional methods used for detecting skeletal fluorosis, therefore, will fail to detect the full range of people suffering from fluoride-induced osteoarthritis.

  • Skeletal Changes in Industrial and Endemic Fluorosis

    Fluorotic changes in bones and joints were evaluated in 105 aluminum workers and 20 residents of an endemic fluorosis region in India.

  • Skeletal Fluorosis in India & China

    In India and China, scientists have repeatedly found that skeletal fluorosis occurs in populations drinking water with just 0.7 to 1.5 ppm fluoride. Although nutritional deficiencies and hot climates make populations in India and China more susceptible to fluoride toxicity than is generally the case in western countries, this fact does not remove the relevance of the Indian and Chinese experience to the situation in fluoridating countries. This is because (a) nutritional deficiencies also exist in the western world, particularly in low-income communities, and (b) some individuals, including those with kidney disease, can be just as -- if not more -- susceptible to fluoride toxicity.